http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101111686-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01008
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0065
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
filingDate 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101111686-B1
titleOfInvention FTC-23K / hrTOO / SS008 Cell line
abstract The present invention relates to a method for evaluating the effects of thyroid hormone impairment on the activity of thyroid peroxidase, specifically, by using a transformed cell line of Accession No. KCLRF-BP-00215 having high thyroid peroxidase activity It can be useful for evaluating the effect on the activity of this thyroid peroxidase.n n n n Thyroid hormone, thyroid peroxidase, transformation
priorityDate 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6474107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522477

Total number of triples: 24.